Page last updated: 2024-09-04

bazedoxifene and dronedarone

bazedoxifene has been researched along with dronedarone in 2 studies

Compound Research Comparison

Studies
(bazedoxifene)
Trials
(bazedoxifene)
Recent Studies (post-2010)
(bazedoxifene)
Studies
(dronedarone)
Trials
(dronedarone)
Recent Studies (post-2010) (dronedarone)
3076924950740327

Protein Interaction Comparison

ProteinTaxonomybazedoxifene (IC50)dronedarone (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.92
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)1.6581
NACHT, LRR and PYD domains-containing protein 3 Mus musculus (house mouse)6.84

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Capuzzi, SJ; Fisher, EG; García-Sastre, A; He, S; Li, H; Martínez-Romero, C; Muratov, EN; Qiu, X; Shinn, P; Sun, W; Tawa, G; Tropsha, A; Xu, M; Zheng, W; Zhu, W1
Byun, SY; Choi, I; Jeon, S; Kim, S; Ko, M; Lee, J; Park, S; Shum, D1

Other Studies

2 other study(ies) available for bazedoxifene and dronedarone

ArticleYear
Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors.
    Journal of medicinal chemistry, 2018, 04-26, Volume: 61, Issue:8

    Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Drug Discovery; Drug Evaluation, Preclinical; Ebolavirus; HeLa Cells; Humans; Molecular Structure; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Virus Internalization

2018
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Niclosamide; Pandemics; Pneumonia, Viral; Pregnenediones; SARS-CoV-2; Vero Cells

2020